Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.120 | 3 | 148741880 | missense variant | C/T | snv | 1.4E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.800 | 1.000 | 1 | 2005 | 2005 | |||||||
|
0.882 | 0.120 | 3 | 148724853 | intron variant | A/G | snv | 2.7E-02 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.882 | 0.120 | 3 | 148724853 | intron variant | A/G | snv | 2.7E-02 |
|
Musculoskeletal Diseases | 0.700 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.882 | 0.120 | 3 | 148724853 | intron variant | A/G | snv | 2.7E-02 |
|
Nervous System Diseases; Mental Disorders | 0.700 | 1.000 | 1 | 2009 | 2009 | |||||||
|
3 | 148722587 | intron variant | C/A | snv | 1.7E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
3 | 148722587 | intron variant | C/A | snv | 1.7E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
3 | 148722587 | intron variant | C/A | snv | 1.7E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
3 | 148722587 | intron variant | C/A | snv | 1.7E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
3 | 148726941 | intron variant | A/C | snv | 0.13 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
3 | 148726941 | intron variant | A/C | snv | 0.13 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
3 | 148742185 | 3 prime UTR variant | T/G | snv | 6.7E-03 | 2.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
3 | 148742185 | 3 prime UTR variant | T/G | snv | 6.7E-03 | 2.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
3 | 148742185 | 3 prime UTR variant | T/G | snv | 6.7E-03 | 2.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
3 | 148742185 | 3 prime UTR variant | T/G | snv | 6.7E-03 | 2.5E-02 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
1.000 | 0.120 | 3 | 148741144 | frameshift variant | -/T | delins | 4.0E-06; 4.0E-06 | 7.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 0 | |||||||||
|
1.000 | 0.120 | 3 | 148741411 | stop gained | C/G;T | snv | 4.1E-06; 1.6E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.700 | 0 | ||||||||||
|
0.630 | 0.560 | 3 | 148742201 | 3 prime UTR variant | A/C | snv | 0.23 | 0.21 |
|
Cardiovascular Diseases | 0.060 | 0.833 | 6 | 2013 | 2019 | ||||||
|
0.742 | 0.160 | 3 | 148741608 | synonymous variant | C/T | snv | 0.49 | 0.41 |
|
Cardiovascular Diseases | 0.030 | 0.333 | 3 | 2012 | 2018 | ||||||
|
0.630 | 0.560 | 3 | 148742201 | 3 prime UTR variant | A/C | snv | 0.23 | 0.21 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.030 | 0.667 | 3 | 2008 | 2013 | ||||||
|
0.630 | 0.560 | 3 | 148742201 | 3 prime UTR variant | A/C | snv | 0.23 | 0.21 |
|
Nutritional and Metabolic Diseases | 0.030 | 1.000 | 3 | 2007 | 2019 | ||||||
|
0.630 | 0.560 | 3 | 148742201 | 3 prime UTR variant | A/C | snv | 0.23 | 0.21 |
|
Cardiovascular Diseases | 0.030 | 1.000 | 3 | 2014 | 2018 | ||||||
|
0.630 | 0.560 | 3 | 148742201 | 3 prime UTR variant | A/C | snv | 0.23 | 0.21 |
|
Cardiovascular Diseases | 0.030 | 1.000 | 3 | 2011 | 2015 | ||||||
|
0.630 | 0.560 | 3 | 148742201 | 3 prime UTR variant | A/C | snv | 0.23 | 0.21 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.030 | 1.000 | 3 | 2009 | 2019 | ||||||
|
0.630 | 0.560 | 3 | 148742201 | 3 prime UTR variant | A/C | snv | 0.23 | 0.21 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.030 | 1.000 | 3 | 2009 | 2019 | ||||||
|
1.000 | 0.040 | 3 | 148708086 | intron variant | A/G;T | snv |
|
Digestive System Diseases | 0.020 | 1.000 | 2 | 2009 | 2013 |